CLDX: Celldex Therapeutics Inc

22.19 USD 0.21 (0.96%)

Secteur: Soins de Santé Base: US Dollar Devise de profit: US Dollar

Le taux de change de CLDX a changé de 0.96% aujourd'hui. Au cours de la journée, l'instrument a été échangé à un minimum de 21.68 et à un maximum de 22.39.

Suivez la dynamique Celldex Therapeutics Inc. Les cotations en temps réel vous aideront à réagir rapidement aux changements du marché. En basculant entre différentes périodes, vous pouvez surveiller les tendances et la dynamique des taux de change par minutes, heures, jours, semaines et mois. Utilisez ces informations pour prévoir les changements du marché et prendre des décisions de trading éclairées.

Graphique en Plein Ecran

CLDX Nouvelles

Zacks 12:13 scPharmaceuticals (SCPH) Soars 8.8%: Is Further Upside Left in the Stock?
Investing 09:11 Jasper Therapeutics stock holds Market Outperform rating at JMP despite setback
Investing 11:27 Celldex stock price target maintained at $50 by H.C. Wainwright
Investing 15:00 Celldex Presents Data Demonstrating Profound Long Term Improvement in Angioedema in Barzolvolimab Phase 2 Study in Chronic Spontaneous Urticaria at EAACI 2025
Benzinga 16:58 Crude Oil Rises 6%; US Consumer Sentiment Surges In June - Senmiao Tech (NASDAQ:AIHS), Chanson International (NASDAQ:CHSN)
Investing 14:33 Celldex shares jump on impressive skin disorder drug data
Investing 14:32 Visa, Mastercard lead Friday’s market cap stock movers
Benzinga 14:11 Unusual Machines, Celldex Therapeutics, RH And Other Big Stocks Moving Higher On Friday - Bunge Global (NYSE:BG), AleAnna (NASDAQ:ANNA)
Investing 11:56 Celldex stock maintains Overweight rating on promising CSU therapy results
Investing 22:12 Celldex Presents Unprecedented 76 Week Results from Barzolvolimab Phase 2 Study in Chronic Spontaneous Urticaria at EAACI Congress 2025
Investing 11:34 Celldex stock rating reiterated at Buy by Canaccord ahead of data release
Investing 20:12 Celldex Announces Upcoming Presentations of Barzolvolimab Phase 2 Data in Chronic Spontaneous Urticaria at EAACI 2025 Congress
Investing 12:05 Celldex Therapeutics appoints new board member
Investing 12:43 Cantor maintains $67 target on Celldex stock amid EoE market growth
TipRanks 11:09 3 Best Stocks to Buy Now, 5/9/2025, According to Top Analysts - TipRanks.com
Benzinga 13:55 This Microsoft Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Thursday - Amentum Holdings (NYSE:AMTM), ArriVent BioPharma (NASDAQ:AVBP)
Benzinga 13:12 Baidu, Informatica And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session - Baidu (NASDAQ:BIDU), AirJoule Technologies (NASDAQ:AIRJ)
Seeking Alpha 19:55 Celldex Therapeutics: Will They Get It Right After A Decade Of Failures?

Range quotidien

21.68 22.39

Range Annuel

14.40 46.90

Clôture Précédente: 21.98
Ouverture: 21.81

Bid: 22.19
Ask: 22.49

Plus Bas: 21.68
Plus Haut: 22.39

Volume: 1.372 K

Changement quotidien: 0.96%
Changement Mensuel: 1.74%

Changement à 6 Mois: 4.33%
Changement Annuel: -45.55%

07 août, jeudi